NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (
Post# of 27
(Total Views: 238)
Posted On: 08/09/2018 5:49:09 PM
NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Inks LOI with Pharmaflorx for the Supply of Cannabis Oils and Isolates
Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has signed a Letter of Intent (“LOI”) with Pharmaflorx Ltd. (“PFX”) for the supply of cannabis oils and isolates. PFX is a privately-held late-stage Access to Cannabis for Medical Purposes Regulations (“ACMPR”) applicant located in Gatineau, Quebec. Per the update, Pivot will acquire a minimum of 1,000 kg/year of cannabis oils or isolates from PFX to manufacture its patented portfolio of biocannabis products. Pivot intends to supply both the Canadian and European Union markets with its suite of patented products following receipt of fitting licenses where regulations permit. “We welcome Pharmaflorx to our growing list of strategic partners and look forward to collaborating with their team to provide a steady and consistent supply of premium cannabis oils and isolates for Pivot’s portfolio of products,” Pivot CEO Dr. Patrick Frankham stated in the news release. “We continue to execute aggressively on our business plan to bring Pivot’s industry leading pipeline of derivatives to market by the end of this year.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has signed a Letter of Intent (“LOI”) with Pharmaflorx Ltd. (“PFX”) for the supply of cannabis oils and isolates. PFX is a privately-held late-stage Access to Cannabis for Medical Purposes Regulations (“ACMPR”) applicant located in Gatineau, Quebec. Per the update, Pivot will acquire a minimum of 1,000 kg/year of cannabis oils or isolates from PFX to manufacture its patented portfolio of biocannabis products. Pivot intends to supply both the Canadian and European Union markets with its suite of patented products following receipt of fitting licenses where regulations permit. “We welcome Pharmaflorx to our growing list of strategic partners and look forward to collaborating with their team to provide a steady and consistent supply of premium cannabis oils and isolates for Pivot’s portfolio of products,” Pivot CEO Dr. Patrick Frankham stated in the news release. “We continue to execute aggressively on our business plan to bring Pivot’s industry leading pipeline of derivatives to market by the end of this year.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)BZAM LTD. (BZAMF) Stock Research Links
Scroll down for more posts ▼